Search

Home
Staff
Sarah Al Ashmori Andy Bryant Thomas Chadwick Svetlana Cherlin Mike Cole Holly Fisher Tony Fouweather Shaun Hiu Dorcas Kareithi Ann Breeze Konkoth Nan Lin Jingky Lozano-Kuehne Helen Mossop Ellen Moss Aritra Mukherjee Jérémie Nsengimana Vicky Ryan Marzieh Shahmandi Moha Shojaei Dawn Teare James Wason Faye Williamson Nina Wilson Sylvia Zhang
PhD students
Ruqayya Azher Nicole Cizauskas Laura Etfer Niamh Fitzgerald Raiann Hamshaw Pela Okorie Samuel Sarkodie Lou Whitehead
Methodology research
Overview Adaptive designs Master protocols Transforming IMID trials
Projects
Publications
News
Courses
Adaptive Designs and Multiple Testing Procedures Leveraging External Information Precision Medicine Clinical Trials
Contact

Helen Mossop

Cost-effectiveness of methenamine hippurate compared with antibiotic prophylaxis for the management of recurrent urinary tract infections in secondary care: a multicentre, open-label, randomised, non-inferiority trial
Methenamine hippurate compared with antibiotic prophylaxis to prevent recurrent urinary tract infections in women: the ALTAR non-inferiority RCT
Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial
Advantages of multi-arm non-randomised sequentially allocated cohort designs for Phase II oncology trials
The WIRE study a phase II, multi-arm, multi-centre, non-randomised window-of-opportunity clinical trial platform using a Bayesian adaptive design for proof-of-mechanism of novel treatment strategies in operable renal cell cancer – a study protocol

Published with Wowchemy — the free, open source website builder that empowers creators.